SAN FRANCISCO (GenomeWeb) – NanoString highlighted the promise of its upcoming technologies as well as its progress in the oncology field at the JP Morgan Healthcare Conference held here this week.

With an eye on the future, CEO Brad Gray said the firm expects its upcoming Digital Spatial Profiling and Hyb & Seq technologies to make major dents in biology and the clinical sequencing markets.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.